Molecular Genetic Etiology and Revisiting the Middle Ear Surgery Outcomes of Branchio-Oto-Renal Syndrome: Experience in a Tertiary Referral Center

Otol Neurotol. 2023 Jun 1;44(5):e319-e327. doi: 10.1097/MAO.0000000000003880. Epub 2023 Apr 22.

Abstract

Objectives: To explore the phenotypes and genotypes of patients with branchio-oto-renal (BOR) and branchio-otic (BO) syndrome, and to analyze the middle ear surgery outcomes qualitatively and quantitatively, proposing a factor usefully prognostic of surgical outcomes.

Study design: Retrospective cohort study.

Setting: Tertiary referral center.

Patients: Eighteen patients with BOR/BO syndrome in 12 unrelated Korean families.

Intervention: Middle ear surgery, including either stapes surgery or ossicular reconstruction.

Main outcome measure: Clinical phenotypes, genotypes, and middle ear surgery outcomes.

Results: Eight probands (66.7%) were confirmed genetically; the condition segregated as a dominant or de novo trait. Six EYA1 heterozygous variants were identified by exome sequencing and multiplex ligation-dependent probe amplification. All variants were pathogenic or likely pathogenic based on the ACMG/AMP guidelines. Two novel EYA1 frameshift variants (p.His373Phefs*4 and p.Gln543Asnfs*90) truncating a highly conserved C-terminal Eya domain were identified, expanding the genotypic spectrum of EYA1 in BOR/BO syndrome. Remarkably, middle ear surgery was individualized to ensure optimal audiological outcomes and afforded significant audiological improvements, especially in BOR/BO patients without enlarged vestibular aqueducts (EVAs). A significant difference in air-bone gap closure after middle ear surgery was noted between the two groups even after adjusting for confounders: -20.5 dB in ears without EVAs (improvement) but 0.8 dB in ears with EVAs (no change or deterioration). Furthermore, the success rate was significantly associated with the absence of EVA.

Conclusions: The results of this study were against the notion that middle ear surgery is always contraindicated in patients with BOR/BO syndrome, and an EVA could be a negative prognostic indicator of middle ear surgery in BOR/BO patients. This may aid to determine the strategy of audiological rehabilitation in patients with BOR/BO syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Branchio-Oto-Renal Syndrome* / genetics
  • Branchio-Oto-Renal Syndrome* / surgery
  • Ear, Middle / surgery
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Molecular Biology
  • Pedigree
  • Protein Tyrosine Phosphatases / genetics
  • Retrospective Studies
  • Tertiary Care Centers

Substances

  • Protein Tyrosine Phosphatases
  • Intracellular Signaling Peptides and Proteins

Supplementary concepts

  • Branchiootic syndrome